PMC:7127067 / 16045-16243
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T132 | 39-40 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T30 | 74-85 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
| T31 | 94-103 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T32 | 112-121 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T33 | 167-178 | Chemical | denotes | ganciclovir | http://purl.obolibrary.org/obo/CHEBI_465284 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T114 | 0-198 | Sentence | denotes | The course of treatment included twice a day oral administration of 75 mg oseltamivir, 500 mg lopinavir, 500 mg ritonavir and the intravenous administration of 0·25 g ganciclovir for 3–14 days [26]. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32113704-32007143-55638578 | 194-196 | 32007143 | denotes | 26 |
| 32113704-32007143-55638578 | 194-196 | 32007143 | denotes | 26 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 580 | 74-85 | Chemical | denotes | oseltamivir | MESH:D053139 |
| 581 | 94-103 | Chemical | denotes | lopinavir | MESH:D061466 |
| 582 | 112-121 | Chemical | denotes | ritonavir | MESH:D019438 |
| 583 | 167-178 | Chemical | denotes | ganciclovir | MESH:D015774 |